Stemirna
Beijing
About Stemirna
Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, and genetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $205.9M
- Funding stage: Late Stage Venture
- Last round: Series D (May 2023)
- Website: stemirna.com
- Phone: 021 - 51572130
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/stemirna-68538 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.